Bromelain and Acetylcysteine (BromAc) alone and in combination with Gemcitabine inhibits subcutaneous deposits of pancreatic cancer after intraperitoneal injection
A. H. Mekkawy, K. Pillai, S. Badar, J. Akhter, V. Kepenekian, K. Ke, S. Valle, D. L. Morris
This study evaluates BromAc alone and in combination with Gemcitabine in a pancreatic cancer mouse model, finding reduced tumor volume, weight, and Ki67 expression compared to 5-FU.
bioRxiv · May 5, 2021 · PreprintCancer Biology